Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05620095 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Study acronym: Act
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Study description revised
    v3
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicenter observational study designed to evaluate the the effectiveness and safety of drug-coated balloon (DCB) angioplasty for below the knee arterial lesions in patients critical with Limb Threatening Ischemia (CLTI).
Trial Details
NCT Number NCT05620095
Lead Sponsor Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Collaborators: Xuanwu Hospital, Beijing, RenJi Hospital, Zhejiang University, First People's Hospital of Hangzhou, Second Affiliated Hospital of Suzhou University, Qingdao University, Chengdu University of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Huashan Hospital
Conditions
(from sponsor)		 Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Related terms Arteriosclerosis, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov